Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnosis and Treatment of Drug-Resistant Tuberculosis.
Caminero JA, Cayla JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Caminero JA, et al. Among authors: cayla ja. Arch Bronconeumol. 2017 Sep;53(9):501-509. doi: 10.1016/j.arbres.2017.02.006. Epub 2017 Mar 27. Arch Bronconeumol. 2017. PMID: 28359606 English, Spanish.
Evaluation of tuberculosis trends in Spain, 1991-1999.
Caminero JA, Caylà JA, Lara N; Working Group on the Current Status of Tuberculosis in Spain. Caminero JA, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2003 Mar;7(3):236-42. Int J Tuberc Lung Dis. 2003. PMID: 12661837
Monitoring changes in anti-tuberculosis treatment: associated factors determined at the time of diagnosis.
Altet MN, Vidal R, Milá C, Rodrigo T, Casals M, Mir I, Ruiz-Manzano J, Jiménez-Fuentes MA, Sánchez F, Maldonado J, Blanquer R, de Souza-Galväo ML, Solsona J, Azlor E, Díaz D, Calpe JL, Caylá JA. Altet MN, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2013 Nov;17(11):1435-41. doi: 10.5588/ijtld.13.0182. Int J Tuberc Lung Dis. 2013. PMID: 24125447
Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment.
Rodrigo T, Casals M, Caminero JA, García-García JM, Jiménez-Fuentes MA, Medina JF, Millet JP, Ruiz-Manzano J, Caylá J; Working Group of the Integrated Programme of Tuberculosis Research. Rodrigo T, et al. Among authors: cayla j. PLoS One. 2016 Aug 3;11(8):e0159925. doi: 10.1371/journal.pone.0159925. eCollection 2016. PLoS One. 2016. PMID: 27487189 Free PMC article.
Update of SEPAR guideline «Diagnosis and Treatment of Drug-Resistant Tuberculosis».
Caminero JA, García-García JM, Caylà JA, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Caminero JA, et al. Among authors: cayla ja. Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):514-521. doi: 10.1016/j.arbres.2020.03.021. Epub 2020 May 20. Arch Bronconeumol (Engl Ed). 2020. PMID: 32446667 English, Spanish.
The Historical Need for a National Tuberculosis Program for Spain.
Caylà JA, Caminero JA. Caylà JA, et al. Arch Bronconeumol (Engl Ed). 2018 Dec;54(12):603-604. doi: 10.1016/j.arbres.2018.06.013. Epub 2018 Jul 23. Arch Bronconeumol (Engl Ed). 2018. PMID: 30049559 English, Spanish. No abstract available.
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment.
García-García JM, Rodrigo T, Casals M, Ruiz-Manzano J, Pascual-Pascual T, Caylà JA; Grupo de Trabajo del Programa Integrado de Investigación en Tuberculosis (PIITB). García-García JM, et al. Among authors: cayla ja. Arch Bronconeumol. 2016 May;52(5):262-8. doi: 10.1016/j.arbres.2015.11.007. Epub 2016 Jan 28. Arch Bronconeumol. 2016. PMID: 26826890 English, Spanish.
582 results